3D Bio printing Market Overview
The 3D Bio printing Market was valued at USD 6.36 billion in 2022, and is anticipated to rise at a CAGR of 24.1% from 2023 to 2030.
3D Bioprinting is a form of additive manufacturing that uses cells and other biocompatible materials as “inks”, also known as bioinks, to print living structures layer-by-layer which mimic the behavior of natural living systems. The global 3D Bio printing market is projected to rise at a considerable rate in the forthcoming years. Several important factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries are significantly contributing to the development of the 3D Bio printing market. Moreover, As well, demand or high throughput models of tissue, used extensively in drug research and discovery processes, is all set to boost the growth in the global 3D Bio printing market.
Furthermore, rising public and private funding to support bioprinting research activities further encouraged market players to improve and strengthen their current manufacturing and distribution capabilities, particularly in emerging markets. This crucial factor is expected to fuel the growth of the 3D Bio printing market to a great extent. Additionally, 3D bioprinting is used widely in various fields such as designing and sizing of bones, vascular grafts, multi-layered skin, cartilaginous structure, tracheal splints, and cardiac tissue. This key factor remarkably contributes to the market’s expansion. Additionally, extensive use in regenerative therapies which includes transplantation and generation will also take part in the market’s development. In addition to this, the advancements in regenerative medicine are also supporting this growth curve over the forecast period.
Covid-19 Impact on 3D Bio printing Market
In addition, the current 3D Bio printing Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the 3D Bio printing Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
3D Bio printing Market Segment Overview
Based on application, the 3D bioprinting market for the Skin rinting applications segment is projected to grow at the highest growth rate during the forecast period. This can be mainly attributed to the technological progressions and new product launches in this application segment, and the growing number of aesthetic and reconstruction surgeries across the world. Moreover, according to the material, the Living Cells segment is expected to hold the largest market share during the forecast period. This is due to the growing R&D in the fields of regenerative medicine and stem cell research, and increasing public and private investments to support research.
3D Bio printing Market, By Component
· Living Cells
· Hydrogels
· Extracellular Matrices
· Other
3D Bio printing Market, By End-User
· Research Organization & Academic Institutes
· Biopharmaceuticals Companies
· Hospital
3D Bio printing Market Regional Overview
In terms of region, North America and Europe are the most prominent region for the global 3D Bio printing market. This is due to the high demand for 3D printing in advanced clinical applications in this region. Additionally, increasing research and development activities in the biotechnology and pharmaceutical industry in several North American and European countries are further escalating the growth of the market in this region. Likewise, the Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Various factors such as growing demand for organ transplants, an increasing number of initiatives by market players for expanding their presence in the APAC, and higher adoption of stem cell research in several APAC countries are significantly supporting the growth of the market in this region.
3D Bio printing Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
3D Bio printing Market Competitor overview
Some key developments and strategies adopted by manufacturers in 3D Bio printing are highlighted below.
· In July 2021, Bengaluru-based Altem Technologies, the provider of 3D printing solutions, has partnered with US-based CELLINK, a bioink company, to accelerate life-science research with 3D Bioprinting in the Indian market. With this partnership, Altem intends to establish a strong presence of bioprinting in the field of medical research and life science applications.
3D Bio printing Market, Key Players
· TeVido BioDevices
· Rainbow Biosciences
· 3D Systems, Inc.
· regenHU
· EnvisionTEC GmbH
· Stratasys Ltd.
· nScrypt, Inc.
· Regenovo Biotechnology Co.
· GeSiM
· Aspect Biosystems Ltd.
The 3D Bio printing Market was valued at USD 6.36 billion in 2022, and is anticipated to rise at a CAGR of 24.1% from 2023 to 2030.
3D Bioprinting is a form of additive manufacturing that uses cells and other biocompatible materials as “inks”, also known as bioinks, to print living structures layer-by-layer which mimic the behavior of natural living systems. The global 3D Bio printing market is projected to rise at a considerable rate in the forthcoming years. Several important factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries are significantly contributing to the development of the 3D Bio printing market. Moreover, As well, demand or high throughput models of tissue, used extensively in drug research and discovery processes, is all set to boost the growth in the global 3D Bio printing market.
Furthermore, rising public and private funding to support bioprinting research activities further encouraged market players to improve and strengthen their current manufacturing and distribution capabilities, particularly in emerging markets. This crucial factor is expected to fuel the growth of the 3D Bio printing market to a great extent. Additionally, 3D bioprinting is used widely in various fields such as designing and sizing of bones, vascular grafts, multi-layered skin, cartilaginous structure, tracheal splints, and cardiac tissue. This key factor remarkably contributes to the market’s expansion. Additionally, extensive use in regenerative therapies which includes transplantation and generation will also take part in the market’s development. In addition to this, the advancements in regenerative medicine are also supporting this growth curve over the forecast period.
Covid-19 Impact on 3D Bio printing Market
In addition, the current 3D Bio printing Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the 3D Bio printing Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
3D Bio printing Market Segment Overview
Based on application, the 3D bioprinting market for the Skin rinting applications segment is projected to grow at the highest growth rate during the forecast period. This can be mainly attributed to the technological progressions and new product launches in this application segment, and the growing number of aesthetic and reconstruction surgeries across the world. Moreover, according to the material, the Living Cells segment is expected to hold the largest market share during the forecast period. This is due to the growing R&D in the fields of regenerative medicine and stem cell research, and increasing public and private investments to support research.
3D Bio printing Market, By Component
- 3D Bioprinters
- Microextrusion bioprinting
- Inkjet 3D Bioprinting
- Laser-assisted Bioprinting
- Magnetic 3D Bioprinting
- Other
- Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
- Research Applications
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical Application
- Skin
- Bone & Cartilage
- Blood Vessels
- Other
· Living Cells
· Hydrogels
· Extracellular Matrices
· Other
3D Bio printing Market, By End-User
· Research Organization & Academic Institutes
· Biopharmaceuticals Companies
· Hospital
3D Bio printing Market Regional Overview
In terms of region, North America and Europe are the most prominent region for the global 3D Bio printing market. This is due to the high demand for 3D printing in advanced clinical applications in this region. Additionally, increasing research and development activities in the biotechnology and pharmaceutical industry in several North American and European countries are further escalating the growth of the market in this region. Likewise, the Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Various factors such as growing demand for organ transplants, an increasing number of initiatives by market players for expanding their presence in the APAC, and higher adoption of stem cell research in several APAC countries are significantly supporting the growth of the market in this region.
3D Bio printing Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
3D Bio printing Market Competitor overview
Some key developments and strategies adopted by manufacturers in 3D Bio printing are highlighted below.
· In July 2021, Bengaluru-based Altem Technologies, the provider of 3D printing solutions, has partnered with US-based CELLINK, a bioink company, to accelerate life-science research with 3D Bioprinting in the Indian market. With this partnership, Altem intends to establish a strong presence of bioprinting in the field of medical research and life science applications.
3D Bio printing Market, Key Players
· TeVido BioDevices
· Rainbow Biosciences
· 3D Systems, Inc.
· regenHU
· EnvisionTEC GmbH
· Stratasys Ltd.
· nScrypt, Inc.
· Regenovo Biotechnology Co.
· GeSiM
· Aspect Biosystems Ltd.
3D Bio printing Market Study Global Market Analysis, Insights and Forecast, 2023-2030
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global 3D Bio printing Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Component
- 5.2.1. 3D Bioprinters
- 5.2.1.1. Microextrusion bioprinting
- 5.2.1.2. Inkjet 3D Bioprinting
- 5.2.1.3. Laser-assisted Bioprinting
- 5.2.1.4. Magnetic 3D Bioprinting
- 5.2.1.5. Other
- 5.2.2. Bioinks
- 5.2.2.1. Natural Bioinks
- 5.2.2.2. Hybrid Bioinks
- 5.2.2.3. Synthetic Bioinks
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Research Applications
- 5.3.1.1. Drug Research
- 5.3.1.2. Regenerative Medicine
- 5.3.1.3. 3D Cell Culture
- 5.3.2. Clinical Application
- 5.3.2.1. Skin
- 5.3.2.2. Bone & Cartilage
- 5.3.2.3. Blood Vessels
- 5.3.2.4. Other
- 5.3.1. Research Applications
- 5.2.1. 3D Bioprinters
- 5.4. Market Analysis, Insights and Forecast – By Material
- 5.4.1. Living Cells
- 5.4.2. Hydrogels
- 5.4.3. Extracellular Matrices
- 5.4.4. Other
- 5.5. Market Analysis, Insights and Forecast – By End-User
- 5.5.1. Research Organization & Academic Institutes
- 5.5.2. Biopharmaceuticals Companies
- 5.5.3. Hospital
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America, Middle East and Africa
6. North America 3D Bio printing Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Component
- 6.2.1. 3D Bioprinters
- 6.2.1.1. Microextrusion bioprinting
- 6.2.1.2. Inkjet 3D Bioprinting
- 6.2.1.3. Laser-assisted Bioprinting
- 6.2.1.4. Magnetic 3D Bioprinting
- 6.2.1.5. Other
- 6.2.2. Bioinks
- 6.2.2.1. Natural Bioinks
- 6.2.2.2. Hybrid Bioinks
- 6.2.2.3. Synthetic Bioinks
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Research Applications
- 6.3.1.1. Drug Research
- 6.3.1.2. Regenerative Medicine
- 6.3.1.3. 3D Cell Culture
- 6.3.2. Clinical Application
- 6.3.2.1. Skin
- 6.3.2.2. Bone & Cartilage
- 6.3.2.3. Blood Vessels
- 6.3.2.4. Other
- 6.3.1. Research Applications
- 6.2.1. 3D Bioprinters
- 6.4. Market Analysis, Insights and Forecast – By Material
- 6.4.1. Living Cells
- 6.4.2. Hydrogels
- 6.4.3. Extracellular Matrices
- 6.4.4. Other
- 6.5. Market Analysis, Insights and Forecast – By End-User
- 6.5.1. Research Organization & Academic Institutes
- 6.5.2. Biopharmaceuticals Companies
- 6.5.3. Hospital
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe 3D Bio printing Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Component
- 7.2.1. 3D Bioprinters
- 7.2.1.1. Microextrusion bioprinting
- 7.2.1.2. Inkjet 3D Bioprinting
- 7.2.1.3. Laser-assisted Bioprinting
- 7.2.1.4. Magnetic 3D Bioprinting
- 7.2.1.5. Other
- 7.2.2. Bioinks
- 7.2.2.1. Natural Bioinks
- 7.2.2.2. Hybrid Bioinks
- 7.2.2.3. Synthetic Bioinks
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Research Applications
- 7.3.1.1. Drug Research
- 7.3.1.2. Regenerative Medicine
- 7.3.1.3. 3D Cell Culture
- 7.3.2. Clinical Application
- 7.3.2.1. Skin
- 7.3.2.2. Bone & Cartilage
- 7.3.2.3. Blood Vessels
- 7.3.2.4. Other
- 7.3.1. Research Applications
- 7.2.1. 3D Bioprinters
- 7.4. Market Analysis, Insights and Forecast – By Material
- 7.4.1. Living Cells
- 7.4.2. Hydrogels
- 7.4.3. Extracellular Matrices
- 7.4.4. Other
- 7.5. Market Analysis, Insights and Forecast – By End-User
- 7.5.1. Research Organization & Academic Institutes
- 7.5.2. Biopharmaceuticals Companies
- 7.5.3. Hospital
- 7.6. Market Analysis, Insights and Forecast – By Country
- 7.6.1. UK
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Russia
- 7.6.7. Rest of Europe
8. Asia Pacific 3D Bio printing Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Component
- 8.2.1. 3D Bioprinters
- 8.2.1.1. Microextrusion bioprinting
- 8.2.1.2. Inkjet 3D Bioprinting
- 8.2.1.3. Laser-assisted Bioprinting
- 8.2.1.4. Magnetic 3D Bioprinting
- 8.2.1.5. Other
- 8.2.2. Bioinks
- 8.2.2.1. Natural Bioinks
- 8.2.2.2. Hybrid Bioinks
- 8.2.2.3. Synthetic Bioinks
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Research Applications
- 8.3.1.1. Drug Research
- 8.3.1.2. Regenerative Medicine
- 8.3.1.3. 3D Cell Culture
- 8.3.2. Clinical Application
- 8.3.2.1. Skin
- 8.3.2.2. Bone & Cartilage
- 8.3.2.3. Blood Vessels
- 8.3.2.4. Other
- 8.3.1. Research Applications
- 8.2.1. 3D Bioprinters
- 8.4. Market Analysis, Insights and Forecast – By Material
- 8.4.1. Living Cells
- 8.4.2. Hydrogels
- 8.4.3. Extracellular Matrices
- 8.4.4. Other
- 8.5. Market Analysis, Insights and Forecast – By End-User
- 8.5.1. Research Organization & Academic Institutes
- 8.5.2. Biopharmaceuticals Companies
- 8.5.3. Hospital
- 8.6. Market Analysis, Insights and Forecast – By Country
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. Australia
- 8.6.5. South East Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa 3D Bio printing Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Component
- 9.2.1. 3D Bioprinters
- 9.2.1.1. Microextrusion bioprinting
- 9.2.1.2. Inkjet 3D Bioprinting
- 9.2.1.3. Laser-assisted Bioprinting
- 9.2.1.4. Magnetic 3D Bioprinting
- 9.2.1.5. Other
- 9.2.2. Bioinks
- 9.2.2.1. Natural Bioinks
- 9.2.2.2. Hybrid Bioinks
- 9.2.2.3. Synthetic Bioinks
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Research Applications
- 9.3.1.1. Drug Research
- 9.3.1.2. Regenerative Medicine
- 9.3.1.3. 3D Cell Culture
- 9.3.2. Clinical Application
- 9.3.2.1. Skin
- 9.3.2.2. Bone & Cartilage
- 9.3.2.3. Blood Vessels
- 9.3.2.4. Other
- 9.3.1. Research Applications
- 9.2.1. 3D Bioprinters
- 9.4. Market Analysis, Insights and Forecast – By Material
- 9.4.1. Living Cells
- 9.4.2. Hydrogels
- 9.4.3. Extracellular Matrices
- 9.4.4. Other
- 9.5. Market Analysis, Insights and Forecast – By End-User
- 9.5.1. Research Organization & Academic Institutes
- 9.5.2. Biopharmaceuticals Companies
- 9.5.3. Hospital
- 9.6. Market Analysis, Insights and Forecast – By Country
- 9.6.1. Brazil
- 9.6.2. Saudi Arabia
- 9.6.3. UAE
- 9.6.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. TeVido BioDevices
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Rainbow Biosciences
- 10.6. 3D Systems, Inc.
- 10.7. regenHU
- 10.8. EnvisionTEC GmbH
- 10.9. Stratasys Ltd.
- 10.10. nScrypt, Inc.
- 10.11. Regenovo Biotechnology Co.
- 10.12. GeSiM
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
